"April 25, 2007, 3:21 pm
A Strong Season for Vaccines
Posted by Jacob Goldstein
Novartis said today it will pay up to $500 million to license an experimental vaccine to help people quit smoking. The vaccine, from a Swiss biotech company called Cytos, is in clinical trials.
The Cytos vaccine is supposed to prompt the body to create antibodies that bind to nicotine in the blood, reducing nicotine uptake in the brain. Nabi Biopharmaceuticals is also at work on a nicotine vaccine called NicVax."
